Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.

Chen F, Bai J, Li W, Mei P, Liu H, Li L, Pan Z, Wu Y, Zheng J.

PLoS One. 2013;8(2):e56241. doi: 10.1371/journal.pone.0056241. Epub 2013 Feb 14.

2.

Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.

Chen F, Wang M, Bai J, Liu Q, Xi Y, Li W, Zheng J.

PLoS One. 2014 Jan 24;9(1):e86917. doi: 10.1371/journal.pone.0086917. eCollection 2014.

3.

Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.

Hemmerlein B, Galuschka L, Putzer N, Zischkau S, Heuser M.

Histopathology. 2004 Dec;45(6):603-11.

PMID:
15569051
4.

RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.

Kim BR, Kang MH, Kim JL, Na YJ, Park SH, Lee SI, Kang S, Joung SY, Lee SY, Lee DH, Min BW, Oh SC.

Oncol Rep. 2016 Nov;36(5):2601-2608. doi: 10.3892/or.2016.5086. Epub 2016 Sep 12.

PMID:
27633042
5.
6.

[Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].

Zhang Y, Wu XH, Cao GH, Li S.

Ai Zheng. 2004 Mar;23(3):326-9. Chinese.

PMID:
15025968
7.

[Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance].

Wang G, Qin W, Zheng J, Wei M, Zhou X, Wang H, Wen W.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Jan;29(1):82-4, 88. Chinese.

PMID:
23294722
8.

MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.

Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM.

Hepatology. 2011 Nov;54(5):1729-40. doi: 10.1002/hep.24577.

PMID:
21793034
9.

High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.

Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB.

Br J Cancer. 2007 Jun 18;96(12):1888-95. Epub 2007 May 15.

10.

Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.

Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND.

FEBS J. 2007 Dec;274(24):6365-77. Epub 2007 Nov 15.

11.

MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.

J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.

PMID:
23454155
12.

The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.

Wang Q, Wang S, Sun SQ, Cheng ZH, Zhang Y, Chen G, Gu M, Yao HJ, Wang Z, Zhou J, Peng YB, Xu MX, Zhang K, Sun XW.

Cancer Biomark. 2016;16(1):1-9. doi: 10.3233/CBM-150535.

PMID:
26484606
13.

Renal cell carcinoma-adjacent tissues enhance mobilization and recruitment of endothelial progenitor cells to promote the invasion of the neoplasm.

Zhao Y, Yu P, Wu R, Ge Y, Wu J, Zhu J, Jia R.

Biomed Pharmacother. 2013 Sep;67(7):643-9. doi: 10.1016/j.biopha.2013.06.009. Epub 2013 Jul 5.

PMID:
23910158
14.

Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.

Liang L, Li L, Zeng J, Gao Y, Chen YL, Wang ZQ, Wang XY, Chang LS, He D.

Oncol Rep. 2012 Sep;28(3):999-1005. doi: 10.3892/or.2012.1874. Epub 2012 Jun 19.

PMID:
22736024
15.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

16.

Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.

Zhang N, Wu P, Shayiremu D, Wu L, Shan H, Ye L, Zhao X, Cai J, Jiang WG, Gong K, Yang Y.

Int J Oncol. 2013 May;42(5):1664-73. doi: 10.3892/ijo.2013.1877. Epub 2013 Mar 29.

PMID:
23545578
17.

microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.

Wu D, Pan H, Zhou Y, Zhou J, Fan Y, Qu P.

Mol Med Rep. 2014 Jun;9(6):2491-8. doi: 10.3892/mmr.2014.2116. Epub 2014 Apr 4.

PMID:
24714873
18.

Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.

Ren J, Li W, Liu H, Yan L, Jiao W, Li D, Tang Y, Gu G, Xu Z.

Urol Oncol. 2013 Oct;31(7):1358-66. doi: 10.1016/j.urolonc.2012.01.004. Epub 2012 Feb 17.

PMID:
22341977
19.

Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.

Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.

Eur Urol. 2009 Feb;55(2):441-9. doi: 10.1016/j.eururo.2008.02.048. Epub 2008 Mar 11.

PMID:
18395325
20.

Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.

Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H.

Cancer Sci. 2013 Nov;104(11):1411-9. doi: 10.1111/cas.12240. Epub 2013 Aug 22.

Supplemental Content

Support Center